美国人群中预测胃黏膜肠上皮化存在的内镜前风险评分的验证
该研究在美国第二个队列中外部验证了既往在退伍军人中开发的胃黏膜肠上皮化(GIM)内镜前预测模型。模型在CHI-St Luke's队列中预测GIM的AUROC为0.62(95%CI 0.57-0.66),预测广泛GIM为0.71(95%CI 0.63-0.79);合并两个队列后模型区分度改善(GIM vs 广泛GIM AUROC:0.74 vs 0.82)。作者认为该模型应在其他美国人群中评估以用于内镜GIM筛查的风险分层。
要点
- 在CHI-St Luke's队列中,模型预测GIM的AUROC为0.62(95%CI 0.57-0.66),预测广泛GIM为0.71(95%CI 0.63-0.79)。
- 合并退伍军人队列与CHI-St Luke's队列后,模型区分度改善:GIM vs 广泛GIM的AUROC为0.74 vs 0.82。
- 作者认为该模型应在其他美国人群中评估,以用于内镜GIM筛查的风险分层。
核心结论
- 内镜前风险预测模型在美国第二个队列中得到验证和更新,对內镜下GIM具有稳健的区分度。
- 作者认为该模型应在其他美国人群中评估,以用于内镜GIM筛查的风险分层。
研究设计与样本
- 外部验证研究:在2017年1月至12月期间,从6家Catholic Health Initiative(CHI)-St Luke's医院(美国德克萨斯州休斯顿)的患者队列中验证既往在退伍军人中开发的模型。
- 既往模型基于休斯顿退伍军人 Affairs 医院的423例GIM病例和1796例对照开发,纳入性别、年龄、种族/民族、吸烟和幽门螺杆菌感染,GIM的AUROC为0.73,广泛GIM为0.82。
- 验证队列包括215例GIM病例(其中55例广泛GIM)和2469例对照;病例定义为任何胃活检样本存在GIM,广泛GIM定义为累及胃窦和胃体。
- 通过合并两个队列进一步优化模型,并使用AUROC评估区分度。
主要发现
- 病例较对照年龄更大(59.8 vs 54.7岁),非白人比例更高(59.1% vs 42.0%),幽门螺杆菌感染比例更高(23.7% vs 10.9%)。
- 模型应用于CHI-St Luke's队列预测GIM的AUROC为0.62(95%CI 0.57-0.66),预测广泛GIM的AUROC为0.71(95%CI 0.63-0.79)。
- 合并退伍军人 Affairs 队列与CHI-St Luke's队列后,两种模型的区分度均改善(GIM vs 广泛GIM AUROC:0.74 vs 0.82)。
关键数值与推荐
- 既往模型在退伍军人队列中GIM的AUROC为0.73,广泛GIM为0.82。
- 验证队列中GIM的AUROC为0.62(95%CI 0.57-0.66),广泛GIM的AUROC为0.71(95%CI 0.63-0.79)。
- 合并队列后GIM的AUROC为0.74,广泛GIM的AUROC为0.82。
临床怎么用
- 作者认为该模型应在其他美国人群中评估,以用于内镜GIM筛查的风险分层。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Surveillance of gastric intestinal metaplasia (GIM) may lead to early gastric cancer detection. Our purpose was to externally validate a predictive model for endoscopic GIM previously developed in a veteran population in a second U.S. METHODS: We previously developed a pre-endoscopy risk model for detection of GIM using 423 GIM cases and 1796 control subjects from the Houston Veterans Affairs Hospital. The model included sex, age, race/ethnicity, smoking, and Helicobacter pylori infection with an area under the receiver-operating characteristic curve (AUROC) of .73 for GIM and .82 for extensive GIM. We validated this model in a second cohort of patients from 6 Catholic Health Initiative (CHI)-St Luke's hospitals (Houston, Tex, USA) from January to December 2017. Cases were defined as having GIM on any gastric biopsy sample and extensive GIM as involving both the antrum and corpus. We further optimized the model by pooling both cohorts and assessing discrimination using AUROC. RESULTS: The risk model was validated in 215 GIM cases (55 with extensive GIM) and 2469 control subjects. Cases were older than control subjects (59.8 vs 54.7 years) with more nonwhites (59.1% vs 42.0%) and H pylori infections (23.7% vs 10.9%). The model applied to the CHI-St Luke's cohort had an AUROC of .62 (95% confidence interval [CI], .57-.66) for predicting GIM and of .71 (95% CI, .63-.79) for predicting extensive GIM. When the Veterans Affairs and CHI-St Luke's cohorts were pooled, discrimination of both models improved (GIM vs extensive GIM AUROC: .74 vs .82). CONCLUSIONS: A pre-endoscopy risk prediction model was validated and updated using a second U.S. cohort with robust discrimination for endoscopic GIM. This model should be evaluated in other U.S. populations to risk-stratify patients for endoscopic GIM screening.
引用
- Tan MC, Sen A, Kligman E, et al. Validation of a pre-endoscopy risk score for predicting the presence of gastric intestinal metaplasia in a U.S. population. Gastrointest Endosc. 2023. PMID: 37207845. doi:10.1016/j.gie.2023.05.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。